HUM-MOLGEN events: CHI's Blood Product Safety

HUM-MOLGEN -> Events -> Meetings and Conferences

July 19, 2002

Cambridge Healthtech Institute, Washington Marriott, Washington, D.C.
February 10-11, 2003

Human blood, plasma and tissue contain many proteins, the extraction and purification of which are of great medical and economic importance. Transmission of infectious diseases via blood transfusion, tissue implantation and the use of processed blood plasma and components have placed a high priority on the development of new strategies for safeguarding the health of millions of patients who receive blood and tissue-derived products every year. The screening of blood for the detection of infectious agents is continuing to advance but is complicated by the presence of new and emerging pathogens. In addition, cost-effectiveness and the threat of emerging and/or crossover infective agents must also be considered. Recent advances and new strategies for the inactivation and removal of infectious agents in whole blood, cord blood, component concentrates, and plasma are the focal point of CHI's Ninth Annual Blood Product Safety conference.

Organized by:

CHI

Invited Speakers:

Dr. Larisa Cervenakova, American Red Cross
Dr. Fred Dombrose, Consortium For Plasma Science LLC
Dr. Kathryn Martin Remington, Bayer Corp.
Dr. David Hammond, American Red Cross
Dr. Hannelore Willkommen, Paul Ehrlich Institute (Germany)

Deadline for Abstracts:

Poster abstracts: January 10, 2003

Registration:

Available on-line.

E-mail:

eeskedal@healthtech.com

Posted by:

Elaine Eskedal

Host:

wks249.healthtech.com